CHINA BIOLOGIC PRODUCTS HOLDINGS, INC. AND SUBSIDIARIES | |||||
RECONCILIATION OF NON-GAAP FINANCIAL MEASURES | |||||
For the Three Months Ended | |||||
December 31, | December 31, | ||||
2018 | 2017 | ||||
USD | USD | ||||
Income from Operations | 42,644,418 | 19,594,582 | |||
Non-cash employee share-based compensation | (4,563,509) | 9,187,749 | |||
Amortization of acquired intangible assets and land use rights | 1,750,585 | - | |||
Expenses related to change of domicile and acquisition of TianXinFu | - | 1,872,012 | |||
Adjusted Income from Operations - Non GAAP | 39,831,494 | 30,654,343 | |||
Net Income Attributable to the Company | 34,907,015 | (24,644,413) | |||
Non-cash employee share-based compensation | (5,419,386) | 8,396,403 | |||
Income tax expense related to U.S. Tax Reform | - | 40,290,367 | |||
Amortization of acquired intangible assets and land use rights | 1,190,398 | - | |||
Expenses related to change of domicile and acquisition of TianXinFu | - | 1,872,012 | |||
Adjusted Net Income Attributable to the Company - Non GAAP | 30,678,027 | 25,914,369 | |||
Diluted EPS - Non GAAP | 0.76 | 0.90 | |||
Weighted average number of shares used in computation of Non GAAP diluted EPS | 39,452,458 | 27,812,319 | |||
For the Years Ended | |||||
December 31, | December 31, | ||||
2018 | 2017 | ||||
USD | USD | ||||
Income from Operations | 146,172,751 | 135,858,505 | |||
Non-cash employee share-based compensation | 23,130,570 | 33,903,283 | |||
Amortization of acquired intangible assets and land use rights | 8,366,196 | - | |||
Expenses related to change of domicile and acquisition of TianXinFu | - | 1,872,012 | |||
Adjusted Income from Operations - Non GAAP | 177,669,517 | 171,633,800 | |||
Net Income Attributable to the Company | 128,056,302 | 67,943,035 | |||
Non-cash employee share-based compensation | 19,706,585 | 31,108,910 | |||
Amortization of acquired intangible assets and land use rights | 5,689,013 | - | |||
Income tax expense (benefit) related to U.S. Tax Reform | (7,519,674) | 40,290,367 | |||
Expenses related to change of domicile and acquisition of TianXinFu | - | 1,872,012 | |||
Adjusted Net Income Attributable to the Company - Non GAAP | 145,932,226 | 141,214,324 | |||
Diluted EPS - Non GAAP | 4.02 | 4.95 | |||
Weighted average number of shares used in computation of Non GAAP diluted EPS | 35,432,959 | 27,605,623 | |||
